Acotec Scientific Holdings Limited (HKG:6669)
Hong Kong · Delayed Price · Currency is HKD 7.88
+0.08 (1.03%)
Jul 31, 2026, 3:50 PM HKT
HKG:6669 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 644.63 | 644.63 | 533.99 | 473.85 | 395.55 | 303.81 |
Revenue Growth | 8.73% | 20.72% | 12.69% | 19.80% | 30.19% | 56.63% |
Gross Profit Gross Profit Growth | 476.31 | 476.31 | 402.72 | 377.42 | 336.35 | 265.94 |
Operating Income Operating Income Growth | 105.81 | 105.81 | 36.05 | 23.13 | -0.96 | 8.57 |
Net Income Net Income Growth | 119.18 | 119.18 | 52.28 | 14.49 | 70.14 | -79.08 |
Earnings Per Share EPS Growth | 0.39 | 0.39 | 0.17 | 0.05 | 0.23 | -0.32 |
EPS Growth | 18.08% | 129.41% | 253.30% | -79.08% | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Mainland China Mainland China Growth | 625.47 | 625.47 | 508.79 | 458.23 | 385.47 | 297.16 |
Other Countries and Regions Other Countries and Regions Growth | 19.16 | 19.16 | 25.2 | 15.62 | 6.16 | 2.34 |
Total Total Growth | 644.63 | 644.63 | 533.99 | 473.85 | 395.55 | 303.81 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 947.97 | 947.97 | 864.19 | 879.21 | 986.46 | 1,137 |
Total Debt Total Debt Growth | 244.39 | 244.39 | 202.92 | 234 | 47.78 | 24.57 |
Net Cash (Debt) Net Cash Growth | 703.58 | 703.58 | 661.27 | 645.21 | 938.67 | 1,113 |
Net Cash Growth | -7.33% | 6.40% | 2.49% | -31.26% | -15.63% | - |
Net Cash Per Share Net Cash Per Share Growth | 2.33 | 2.33 | 2.20 | 2.14 | 3.13 | 4.49 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 150.27 | 150.27 | 102.79 | -12.88 | -68.76 | -10.48 |
Capital Expenditures CapEx Growth | -22.44 | -22.44 | -52.06 | -79.6 | -43.41 | -20.36 |
Free Cash Flow Free Cash Flow Growth | 127.83 | 127.83 | 50.73 | -92.48 | -112.17 | -30.84 |
Free Cash Flow Growth | -19.60% | 151.99% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.89% | 73.89% | 75.42% | 79.65% | 85.04% | 87.53% |
Operating Margin | 16.41% | 16.41% | 6.75% | 4.88% | -0.24% | 2.82% |
Pretax Margin | 18.95% | 18.95% | 9.85% | 3.05% | 17.78% | -22.13% |
Profit Margin | 18.49% | 18.49% | 9.79% | 3.06% | 17.73% | -26.03% |
FCF Margin | 19.83% | 19.83% | 9.50% | -19.52% | -28.36% | -10.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 1, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 18.16 | 31.90 | 33.63 | 221.49 | 67.90 | - |
Forward PE | 15.79 | 26.52 | 16.75 | 26.85 | 49.02 | 22.25 |
P/FCF Ratio | 17.36 | 29.74 | 34.66 | - | - | - |
PS Ratio | 3.44 | 5.90 | 3.29 | 6.77 | 12.04 | 9.70 |